US 7994165
Aryl aniline derivatives as β2 adrenergic receptor agonists
granted A61PA61P11/00A61P11/06
Quick answer
US patent 7994165 (Aryl aniline derivatives as β2 adrenergic receptor agonists) held by Theravance, Inc. expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue Aug 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61P, A61P11/00, A61P11/06, A61P43/00